Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Opinion - (2023) Volume 11, Issue 4

Vaccine Development and Distribution: CDC's Efforts in Disease Prevention

Karin Taitel*
Department of Allergy and Infectious Diseases, University of Bethesda, Maryland, United States
*Correspondence: Karin Taitel, Department of Allergy and Infectious Diseases, University of Bethesda, Maryland, United States, Email:

Received: 18-Jun-2023 Published: 14-Jul-2023, DOI: 10.36648/2386- 5180.23.11.472


Vaccine development and distribution play a pivotal role in preventing the spread of infectious diseases and safeguarding public health. The Centres for Disease Control and Prevention (CDC), as the leading national public health agency in the United States, plays a vital role in coordinating efforts to develop and distribute vaccines. This article will delve into the CDC's endeavours in disease prevention through its comprehensive approach to vaccine development, including research, testing, and distribution strategies [1].

The CDC actively engages in research and development initiatives to create effective vaccines against various diseases. Through collaborations with public and private entities, the CDC identifies key pathogens and conducts extensive research to understand their characteristics, transmission, and potential vaccine targets. This knowledge forms the foundation for the development of safe and effective vaccines. The CDC utilizes its vast network of scientists, epidemiologists, and healthcare professionals to conduct preclinical studies, including laboratory testing and animal trials, to assess vaccine safety and efficacy. This rigorous process ensures that only the most promising candidates progress to clinical trials, minimizing risks to human participants [2].

Once vaccine candidates show promise in preclinical studies, the CDC plays a vital role in organizing and overseeing clinical trials. These trials involve human volunteers and are conducted in multiple phases to evaluate safety, dosage, and efficacy. The CDC collaborates with pharmaceutical companies, academic institutions, and other stakeholders to design clinical trial protocols, recruit participants, and monitor the progress of trials. These efforts ensure that vaccines meet rigorous safety and efficacy standards before they are approved for public use.

The CDC also prioritizes vaccine safety monitoring post-approval. Through its Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Data link (VSD), the CDC continuously monitors and investigates any potential adverse effects associated with vaccines [3]. This active surveillance enables the identification of rare side effects and the implementation of timely interventions, further ensuring public confidence in vaccination programs.

The CDC plays a central role in coordinating the distribution and administration of vaccines across the United States. It collaborates with federal, state, and local partners to develop comprehensive vaccination strategies and ensure equitable access to vaccines.

The CDC's Advisory Committee on Immunization Practices (ACIP) provides guidance on vaccine prioritization and administration [4]. This expert committee reviews scientific evidence and formulates recommendations for vaccine use, taking into account factors such as disease burden, vaccine effectiveness and population demographics.

To facilitate vaccine distribution, the CDC operates the Vaccine Tracking System (VTrckS), a secure online platform that monitors vaccine inventory and distribution in real-time. This system enables efficient allocation of vaccines to healthcare providers, ensuring adequate supply and reducing wastage. Furthermore, the CDC works closely with state and local health departments to establish vaccination sites, including clinics, pharmacies, and mobile units. It provides training and resources to healthcare providers on proper vaccine storage, handling, and administration techniques, ensuring the integrity and effectiveness of the vaccination process [5].


The Centres for Disease Control and Prevention (CDC) play a crucial role in vaccine development and distribution as part of its broader efforts in disease prevention. The CDC is committed to safeguarding public health by conducting research, monitoring infectious diseases, and collaborating with various stakeholders to develop safe and effective vaccines. The CDC's vaccine development efforts involve extensive research, including epidemiological studies, clinical trials, and laboratory investigations. Through these activities, the CDC identifies and understands the pathogens causing diseases, assesses their impact on public health, and determines the most effective strategies for vaccine development.


  1. Banks HT, Castillo-Chavez C (2003). Bioterrorism: mathematical modeling applications in homeland security. SIAM J Appl Math.
  2. Indexed at, Google Scholar, Cross Ref

  3. Daulaire N (2014). HHSâ??Supporting Global Immunization through Policies, Programs and Partnerships. Public Health Rep. 129:1-3.
  4. Indexed at, Google Scholar, Cross Ref

  5. Excler JL, Saville M, Berkley S, Kim JH (2021). Vaccine development for emerging infectious diseases. Nature Med. 27(4):591-600.
  6. Indexed at, Google Scholar, Cross Ref

  7. Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q (2021). A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Central Science. 7(4):512-33.
  8. Indexed at, Google Scholar, Cross Ref

  9. Willingham III AL, Harrison LJ, Fevre EM, Parkhouse ME (2008). Inaugural meeting of the cysticercosis working group in Europe. Emerg Infect Dis. 14(12):2.
  10. Indexed at, Google Scholar, Cross Ref

Citation: Taitel K (2023) Vaccine Development and Distribution: CDC's Efforts in Disease Prevention. Ann Clin Lab Res. Vol.11 No.4:472